Filtered By:
Source: Journal of Neurology, Neurosurgery and Psychiatry
Condition: Dementia
Infectious Disease: COVID-19
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
What should we do about vaccination of patients on anti-CD20 antibody therapy?
The SARS-CoV-2 antibody response was decreased in patients with multiple sclerosis (MS) who were infected with COVID-19 and received anti-CD20 therapy Vaccination efforts for COVID-19 are currently underway worldwide. At present, there is insufficient evidence of the vaccine’s efficacy and safety in patients with neurological diseases, such as stroke, dementia and intractable neurological diseases. Despite the fact that many patients with neurological diseases are elderly and often have systemic complications, I believe that neurologists should nonetheless actively recommend vaccination to their patients. However, th...
Source: Journal of Neurology, Neurosurgery and Psychiatry - December 14, 2021 Category: Neurosurgery Authors: Shimohata, T. Tags: COVID-19 Editorial commentaries Source Type: research
